11/15/2018
Just in time for World Diabetes Day, Willamette Week ran this piece on the insulin price and access crisis in Oregon. Oregonians with type 1 and insulin-requiring type 2 are struggling as insurers demand they pay list price for insulin, while Moda Health (quoted in this piece) tries to convince our legislators and insurance regulators that it's fine for insurers to treat the huge rebates manufacturers pay back to them as "general revenue." The juxtaposition of human suffering vs. corporate and government indifference in this article is heartbreaking. The Type 1 Diabetes Defense Foundation is a Eugene-based nonprofit, and we've been been grateful for help of all kinds from people in the Mama I'm Low community as we've been pushing for justice on this important issue. There's a link to T1DF in the Willamette Week article if you'd like to know more about—or support—our work.Just in time for World Diabetes Day, Willamette Week ran this piece on the insulin price and access crisis in Oregon. Oregonians with type 1 and insulin-requiring type 2 are struggling as insurers demand they pay list price for insulin, while Moda Health (quoted in this piece) tries to convince our legislators and insurance regulators that it's fine for insurers to treat the huge rebates manufacturers pay back to them as "general revenue." The juxtaposition of human suffering vs. corporate and government indifference in this article is heartbreaking. The Type 1 Diabetes Defense Foundation is a Eugene-based nonprofit, and we've been been grateful for help of all kinds from people in the Mama I'm Low community as we've been pushing for justice on this important issue. There's a link to T1DF in the Willamette Week article if you'd like to know more about—or support—our work.
U.S. insulin prices, which are four times higher than prices in other developed countries, are an enduring mystery. Two Oregonians say they have solved the puzzle.